4//SEC Filing
Robbins Andrew R 4
Accession 0001209191-22-039328
CIK 0001708493other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:49 PM ET
Size
5.5 KB
Accession
0001209191-22-039328
Insider Transaction Report
Form 4
Robbins Andrews R
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2022-06-22+10,167→ 10,167 totalExercise: $2.01Exp: 2032-06-21→ Common Stock (10,167 underlying)
Footnotes (1)
- [F1]The stock option will fully vest and become exercisable on June 21, 2023, subject to the continuous service of the Reporting Person with the Issuer on such date.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001590157
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 6:49 PM ET
- Size
- 5.5 KB